Doctronic navigation menu Log In
Doctronic navigation menu

Contents
  • How Factor V Leiden Increases Risk
  • Genetic and Environmental Influences
  • Common Misconceptions

The Hidden Risks of Factor V Leiden

The Hidden Risks of Factor V Leiden

Why It Matters

Factor V Leiden is a genetic mutation that can increase your risk of certain blood clots. Knowing your risk factors is crucial for prevention.
Contents
  • How Factor V Leiden Increases Risk
  • Genetic and Environmental Influences
  • Common Misconceptions

How Factor V Leiden Increases Risk

Factor V Leiden alters a blood protein, making it resistant to a key anticoagulant action. This leads to an increased risk of venous thromboembolism (VTE). However, not everyone with the mutation will experience clotting issues.

Genetic and Environmental Influences

The risk of clotting increases if you inherit the mutation from both parents or have other genetic disorders. External factors like age, pregnancy, or contraceptive use can also spike the risk. Understanding these can help manage and mitigate potential health issues.
Factor V Leiden is a genetic mutation that affects blood clotting, increasing the risk of venous thromboembolism.

Common Misconceptions

One common misconception is that everyone with Factor V Leiden will have blood clots. In reality, many never experience symptoms. Lifestyle choices and other health conditions can play significant roles in whether complications develop.

FAQs

What does Factor V Leiden affect?

It affects a protein involved in blood clotting.

Does everyone with the mutation have health issues?

No, many live symptom-free.

What are key risk factors?

Genetics, age, pregnancy, and hormone use.

Can lifestyle changes help?

Yes, understanding your risks can guide preventive measures.

The Bottom Line

Factor V Leiden presents risks, but being informed helps manage them effectively.
Talk to Doctronic about assessing your risk factors today!
Additional References
  1. Juul K, Tybjaerg-Hansen A, Schnohr P, et al. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004; 140:330.
  2. Simioni P, Prandoni P, Lensing AW, et al. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997; 336:399.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.